CANNABINOIDS AS AN INGREDIENT | Keith Bushfield (CEO, Rexis Biotech)
Oct 02, 2023•15 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this episode, we are joined by Keith Bushfield. Keith is the CEO of Rexis Biotech, a company focused on developing innovative medical technologies. Prior to joining Rexis, Keith held various leadership positions in the biotechnology industry, including executive roles at popular companies such as Biogen and Genentech. Under his guidance, Rexis has made significant strides in the development of new treatments for various diseases, including cancer and neurological disorders. Topics: 1. Cannabinoids As An Ingredient 2. Nanotechnology * Twitter - @TheCannabisRev2 * LinkedIn - @thecannabisreview * Episode Library - https://www.thecannabisreview.ie + Rexis Biotech https://rexissystems.com
For the best experience, listen in Metacast app for iOS or Android